Aktie A14Z67 STRONGBRIDGE BIOPHARMA
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Strongbridge Biopharma

Aktien

A14Z67

IE00BYZ5XL97

SBBP

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from S&P Global BMI Index
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from S&P TMI Index
STRONGBRIDGE BIOPHARMA PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
Strongbridge Biopharma : plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
Strongbridge Biopharma plc(NasdaqGS:SBBP) dropped from NASDAQ Composite Index
Xeris Pharmaceuticals, Inc. completed the acquisition of Strongbridge Biopharma plc from HealthCap VI L.P., a fund managed by Odlander, Fredrikson & Co. AB, Caxton Alternative Management LP, and others.
Strongbridge Biopharma : Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals : Shareholders Approve Pending Strongbridge Biopharma Acquisition
Strongbridge Biopharma : Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc (Form 8-K)
STRONGBRIDGE BIOPHARMA PLC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
Strongbridge Biopharma : Says Glass Lewis Recommends Shareholders Vote in Favor of Proposed Deal with Xeris
Xeris Pharmaceuticals : Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
STRONGBRIDGE BIOPHARMA PLC : Other Events (form 8-K)
Xeris Pharmaceuticals : ISS Recommends Xeris, Strongbridge Shareholders Vote in Favor of Proposed Deal
Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
STRONGBRIDGE BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Strongbridge Biopharma: Q2 Earnings Snapshot
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14Z67 Aktie
  4. Nachrichten Strongbridge Biopharma
  5. Andere Sprachen